Revvity

سعر السهم
97.58
التغيير اليومي
0.46 0.47%
شهريا
-14.93%
سنويا
-15.51%
Q1 التوقعات
97.22




Ebitda تغيير تاريخ
Agilent USD 466M 5M 2025-06
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Celltrion KRW 374.56B 352.67B 2025-09
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 167M 30M 2025-09
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Exact Sciences USD 135.42M 2.8M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Illumina USD 332M 12M 2025-09
Intuitive Surgical USD 919.7M 21M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 15.51M 3.39M 2025-06
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 588.1M 24.1M 2025-12
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 10.3M 4.2M 2025-09
Neuren Pharmaceuticals AUD 176.7M 166.79M 2024-12
OraSure Technologies USD 920K 9.87M 2024-06
Organigram Holdings CAD 6.15M 455K 2025-09
Pacific Biosciences Of California USD -73.24M 3.12M 2023-09
Pharma Mar EUR -1.98M 28.13M 2025-09
Qiagen NV USD 249.69M 56.53M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sartorius EUR 277.4M 30.5M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Tilray USD 8.36M 1.82M 2025-09
Waters USD 380.97M 85.83M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06


Revvity - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.